These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 16325772)
1. Altered apolipoprotein A-V expression during the acute phase response is independent of plasma triglyceride levels in mice and humans. Becker S; Schomburg L; Renko K; Tölle M; van der Giet M; Tietge UJ Biochem Biophys Res Commun; 2006 Jan; 339(3):833-9. PubMed ID: 16325772 [TBL] [Abstract][Full Text] [Related]
2. Serum apolipoprotein A-V in patients with coronary artery disease and its association with triglyceride. Yang Y; Walijee SM; Jin J; Zhao SP; Peng DQ J Clin Lipidol; 2012; 6(5):462-8. PubMed ID: 23009782 [TBL] [Abstract][Full Text] [Related]
3. A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration. Ishihara M; Kujiraoka T; Iwasaki T; Nagano M; Takano M; Ishii J; Tsuji M; Ide H; Miller IP; Miller NE; Hattori H J Lipid Res; 2005 Sep; 46(9):2015-22. PubMed ID: 15961791 [TBL] [Abstract][Full Text] [Related]
6. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome. Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634 [TBL] [Abstract][Full Text] [Related]
7. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics. Chan DC; Watts GF; Nguyen MN; Barrett PH Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):590-6. PubMed ID: 16410456 [TBL] [Abstract][Full Text] [Related]
8. Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL. Khovidhunkit W; Duchateau PN; Medzihradszky KF; Moser AH; Naya-Vigne J; Shigenaga JK; Kane JP; Grunfeld C; Feingold KR Atherosclerosis; 2004 Sep; 176(1):37-44. PubMed ID: 15306172 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A-V level may contribute to the development of obesity-associated dyslipidemia. Yoshino Y; Okada T; Abe Y; Odaka M; Kuromori Y; Yonezawa R; Iwata F; Mugishima H Obes Res Clin Pract; 2013; 7(5):e415-9. PubMed ID: 24304484 [TBL] [Abstract][Full Text] [Related]
10. Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice. van der Vliet HN; Schaap FG; Levels JH; Ottenhoff R; Looije N; Wesseling JG; Groen AK; Chamuleau RA Biochem Biophys Res Commun; 2002 Aug; 295(5):1156-9. PubMed ID: 12135615 [TBL] [Abstract][Full Text] [Related]
11. Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis. Beckstead JA; Oda MN; Martin DD; Forte TM; Bielicki JK; Berger T; Luty R; Kay CM; Ryan RO Biochemistry; 2003 Aug; 42(31):9416-23. PubMed ID: 12899628 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation. Shu X; Nelbach L; Ryan RO; Forte TM Biochim Biophys Acta; 2010 May; 1801(5):605-8. PubMed ID: 20153840 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlement. Sharma V; Ryan RO; Forte TM Biochim Biophys Acta; 2012 May; 1821(5):795-9. PubMed ID: 22209939 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion. VerHague MA; Cheng D; Weinberg RB; Shelness GS Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2501-8. PubMed ID: 24030551 [TBL] [Abstract][Full Text] [Related]
15. Influence of apoA-V gene variants on postprandial triglyceride metabolism: impact of gender. Olano-Martin E; Abraham EC; Gill-Garrison R; Valdes AM; Grimaldi K; Tang F; Jackson KG; Williams CM; Minihane AM J Lipid Res; 2008 May; 49(5):945-53. PubMed ID: 18263854 [TBL] [Abstract][Full Text] [Related]
18. Effects and mechanisms of apolipoprotein A-V on the regulation of lipid accumulation in cardiomyocytes. Luo J; Xu L; Li J; Zhao S Lipids Health Dis; 2018 Mar; 17(1):46. PubMed ID: 29530023 [TBL] [Abstract][Full Text] [Related]
19. Characterization of apolipoprotein A-V structure and mode of plasma triacylglycerol regulation. Wong K; Ryan RO Curr Opin Lipidol; 2007 Jun; 18(3):319-24. PubMed ID: 17495607 [TBL] [Abstract][Full Text] [Related]